HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Verdi J. DiSesa Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by DiSesa, V. J. Articles by Eisen, H. J. Search for Related Content PubMed PubMed Citation Articles by DiSesa, V. J. Articles by Eisen, H. J.

Ann Thorac Surg 1994;58:1050-1053
© 1994 The Society of Thoracic Surgeons

---

Articles

Cardiac transplant donor heart allocation based on prospective tissue matching

^a Department of Surgery, Medical College of Pennsylvania, Philadelphia, Pennsylvania, USA
^b Departments of Surgery and Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA

Accepted for publication February 11, 1994.

^_* Address reprint requests to Dr DiSesa, Division of Cardiothoracic Surgery, Medical College of Pennsylvania, 3300 Henry Ave, Philadelphia, PA 19129.

The present priority scheme for the allocation of donor hearts based on patient acuity and waiting time contributes to the escalating costs of heart transplantation, ignores the potential outcome advantages of prospective tissue matching, and is vulnerable to manipulation. Costs have trebled in recent years, as recipients frequently spend weeks before transplantation as inpatients in intensive care units and become more susceptible to nosocomial complications. The findings from an international cooperative study suggest that patient survival is correlated with the level of histocompatibility (ie, human lymphocyte antigen [HLA]) matching. We observed a similar inverse association between retrospective fortuitous HLA matching and the risk of rejection in 39 patients undergoing heart transplantation over a 29-month period (p = 0.03 by nonparametric analysis). These observations prompted us to consider the feasibility of donor heart allocation based on the degree of HLA matching and waiting time alone. Current methods permit the accurate determination of HLA type in a matter of hours using donor peripheral blood alone. Human lymphocyte antigen typing, therefore, could be performed locally before organ harvesting, making issues of donor heart preservation irrelevant. We evaluated the extent of HLA matching that might be achieved practically. Forty-seven patients on our waiting list during calendar year 1991 were tested retrospectively for HLA matching with all geographically accessible 1991 heart donors identified by the United Network for Organ Sharing for all donors from hospitals east of the Mississippi River. Patients were matched for compatible blood type and six HLA antigens (two each for A, B, and DR) with 1,068 donors. For patients with blood type O (n = 30), 90% ( [equation]) had at least one donor with four antigens matched and 37% ( [equation]) and 20% ( [equation]) had at least one five- or six-antigen match, respectively. For patients with blood type A (n = 12) 100% ( [equation]) and 50% ( [equation]) had four- or five-antigen matches, respectively. Results were similar for blood type B (n = 2) and AB (n = 3) patients. A high degree of prospective HLA matching is achievable in heart transplantation with currently available technology. An allocation system based on matching and waiting time alone would be readily verifiable, would reduce the cost of heart transplantation by directing more hearts to outpatient recipients, and could improve outcome by achieving higher degrees of tissue compatibility. These factors constitute a rationale to consider other than the traditional triage criteria for the allocation of donor hearts.